CONGENITAL FACTOR VII DEFICIENCY
Clinical trials for CONGENITAL FACTOR VII DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new CONGENITAL FACTOR VII DEFICIENCY trials appear
Sign up with your email to follow new studies for CONGENITAL FACTOR VII DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot could tame rare bleeding disorder
Disease control Recruiting nowThis study tests a new drug called sutacimig in 18 adults with a rare inherited bleeding disorder (factor VII deficiency). The drug is given as a single shot under the skin to see if it is safe and can help prevent bleeding. The goal is to find a more convenient treatment option …
Matched conditions: CONGENITAL FACTOR VII DEFICIENCY
Phase: PHASE2 • Sponsor: Hemab ApS • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New shot aims to cut bleeding in hemophilia patients
Disease control Recruiting nowThis study tests an experimental injection called SR604 in 76 adults with hemophilia A, B, or congenital factor VII deficiency. The goal is to see if it is safe and can reduce bleeding episodes. Participants will receive either a single dose or multiple doses, and researchers wil…
Matched conditions: CONGENITAL FACTOR VII DEFICIENCY
Phase: PHASE1, PHASE2 • Sponsor: Shanghai RAAS Blood Products Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC